LBT 0.00% 1.6¢ lbt innovations limited

Why the hype?, page-5

  1. 79 Posts.
    lightbulb Created with Sketch. 4
    I look at culture plates for a living and we are unable to issue a report based on the colony morphology of a bacterium alone, it's ID must be confirmed by further bench-top tests or methods such as MALDI-TOF. Use of chromogenic agars with the APAS system MAY allow reporting off morphology alone but I imagine it would be a tough task convincing end users and regulatory authorities to have 100% confidence that they can abandon confirmatory testing.. Both Keistra and Copan systems will (or soon will) have the smarts to
    recognise and pick significant bacterial colonies for MALDI-TOF and AST testing so again I wonder where APAS will revolutionise the microbiology laboratory. Here is a good microbiologists review of the 2 systems already in use:
    http://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(16)00006-9/abstract
 
watchlist Created with Sketch. Add LBT (ASX) to my watchlist
(20min delay)
Last
1.6¢
Change
0.000(0.00%)
Mkt cap ! $27.98M
Open High Low Value Volume
1.6¢ 1.6¢ 1.6¢ $310 19.37K

Buyers (Bids)

No. Vol. Price($)
8 2238899 1.5¢
 

Sellers (Offers)

Price($) Vol. No.
1.7¢ 306951 1
View Market Depth
Last trade - 10.37am 11/10/2024 (20 minute delay) ?
LBT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.